-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK CHIEF SCIENTIFIC OFFICER (CSO): WE EXPECT TO HAVE AT LEAST FIVE ORAL DRUG CANDIDATES IN CLINICAL DEVELOPMENT BY THE END OF THIS YEAR

Reuters·09/21/2026 08:49:04